BTIG downgraded Bionano Genomics to Neutral from Buy.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BNGO:
- BioNano Genomics Restructures for Cost Efficiency and Cash Flow Optimization
- Bionano Genomics downgraded at Scotiabank on limited capital market visibility
- Bionano Genomics downgraded to Sector Perform from Outperform at Scotiabank
- Bionano Genomics price target lowered to $5.20 from $6.80 at Ladenburg
- Bionano Genomics Reported Earnings. Did it Beat Estimates?